Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Topped up 1.5k at 4.3. Thanks very much.
I sold out at 17p at a juicy loss. Thank God as I eventually clawed the loss back a reasonable wedge of the remaining equity over the past 12-18 months. This can only go one way which is it being sold to a 3rd Party with RF the main beneficiary. In many ways the drawdown facility is essentially a transfer of ownership and its happening under your noses. There are better investments elsewhere as this is going to be at least 2 years before it gets to some sort of break even point. It simply won't be the same entity over that timeframe. Not to say there can't be a race to 20p but it'll get sold into.
Because I'm being extra kind Stocksaint and I don't disagree with you that 1.5 M is skinny! Even with tax credits and Devote, the 1.5 m offers a year of runway at most. This isn't enough. They need 18months - 2 years worth. I reckon a break even is around 2026/2027 at best. Definition of madness is to expect anything different anytime soon!!!
Excited cos youre a mug. Going concern issue unless major dilution. Rog and I both said 4-5p which is about right. Mcap of 5.5 M and i reckon 1.5 m needed. Do the math and get optimistic on the other side when dust settles from this disastrous set of results.
I ll accept that Jimi. Though all a tick higher than suggested 2-3 yrs ago by management. What i can t accept is buffoons giving totally false data claiming the global market for AIHL 450m+ like 4 times the size. Gdr will only capture a fraction anyway. Maybe 10%-15%over 5-10 years. Nonetheless thats 10-15m from one assay. Just got to think long term and top drawer the investment.
FFS. The uk market is worth 5m. The eu market circa 12-15m and the US is apparently 25m. Do you not read RNSs? DYOR.
SystemZero author of "how to catch a falling knife for dummies" Chapter 1. 20p is low lucky if you can buy now. Chapter 2. 12p is crazy low I'm loading up. Chapter 3. Anything under 10 p is a steal this will explode. Chapter 4. 8p you can't go wrong son. Chapter 5. 6p. Expect a hard bounce before the end of day. Look at all the buys.
Hmmmm I wonder what the next Chapter is..."I'll be right eventually" :-:::::::::::::::::::::::::::::-))))
Gloria - Exactly!! I thought the UK market was 3-5 million but we can go with 8.5M" breakeven for GDR is probably 4M ish!! To get close to that you need to saturate the UK market which can't happen until final guidance. In the meantime, they want to spaff money up the wall with the FDA and Europe. From here you can see the strategy staring you in the face!!!!! If GDR was about surviving in its own right, you'd find a partner in the States who has contacts and experience navigating the as yet, not understood, regulatory frameworks and requirements. This is all about selling the business before it commercialises and creating a shop window of approval processes underway or over the line. Its up to SHs if they trust another dilution in belief that GDR will realise proper value through a sale. I don't and I won't cos any firm that can't stand on its own two feet is at the vagaries of the market.
Nothing can or will be sold in the next 12 months of any significance dear chap. Its in plain English despite the Emperors new clothes in James Cheek. How long is the NICE data and sample collection running until full reccomendation? Do you think the NHS or any Trust will adopt this until that happens??All other markets are behind the UK in development so wake the F* up. This is 2nd half of 2025 until it turns a corner with risks front and centre beforehand. To be clear I have every expectation that by 2030 GDR will be a multi-million revenue spinner. However what you are blind to is that existing shareholders will be massively diluted by then via placements/RF or a cheap sell. Any firm that can't make money is at the vagaries of the market. And its never pretty.
BigAL you are an absolute tool. You can do the Maths all you like. Without a proper cash injection you have 2 major issues. This isn't solely about "keeping the lights on" and scraping by on handouts. You won't make one sale into the NHS if you can't demonstrate stability and a roadworthy business. It will never get through any Supplier Risk Assessment with "going concern" statements from the CEO. Why would the NHS or anyone else start changing ways of working and behaviours to incorporate something that is at risk of a short shelf life? 2. GDR is not the only firm in this space and simply have to keep investing to demonstrate they are entirely current. The AI market is constantly evolving. You can just scrape by without putting proper investment down. If you don't your R&D team walk and you're left with limited capabilities which are then very difficult to attract back in to the business. They are the lifeblood and there is a war on limited talent going on. This is why major cash is needed to see GDR through the next 18 months - 2 years.
If you look at the last raise Budd stated the raise was in part to cover the FDA application. Now they want more for the same process??!!! Worse they still don t know what the regulatory process is. Sorry but its plain daft. They should find a US distribution partner who can manage and fund the process for a slice of the cake and put all resource into the most developed markets in the pipeline. Dont come asking for more money for the same damn thing
This is actually a tragi-comedy. Big Al is going to take todays Data and feed it into his calculations:-:::::-))). Or you could save everyone your embarassment and take the new CEOs advice that it needs to raise substantial funds in Q1 to remain a going concern. No wait....you re going to come up with better numbers. What an education ahahahah
I don't disagree StockSaint. As called correctly the dial hasn't moved on Sales (an extra 6K) you couldn't write it. Without blowing my trumpet back in 2021 I said this would take 4/5 years and I'm spot on. I have banged on since then that the long term needs of the business and the short term funding in place was the issue which is why I sold at a loss i might add. thank god i did. Roll on a year and what are we expecting?? There won't be any real sales still. they don't even know what the regulatory process with the FDA even looks like! Yet alone moving the needle there. NICE data collection will take another year as well. The only thing that matters is breakeven and I think the board should take equity as payment and minimal cash. They should behave like entrepreneurs do with their own businesses pre commercialisation. Instead they expect full pay and so I cannot and will not believe a goddam word they say until they are fully vested. That won't happen which is why S/hs should revolt and force a sale. You'd likely get 10-12p.
Can you not read Jimi???There is going to be a raise from existing shareholders its there in B&W
Sorry to rant but why don t the board take Zero salary like entrpreneurs and take equity instead....riddle me that. Answer. They want you to pay their salaries like total mugs. F/O to them.
They will allow drawdowns but it ll be on such pernicious terms that current SHs are just seeing any ROI evaporate. RF will own a huge chunk of GDR by end.
Systemzero you are persistently deluding yourself and i don t know why. A refusal to accept what is in front of your eyes.
Shareholders must simply say no. I promise you this on my heart. You will put more cash in and they will spend that money on livelihoods aka salaries and you ll be in the same boat regardless in 12-18months. Force this business to be sold. Its the best thing for it and what it needs. How a new CEO can claim the money is for R@D is horsesht. Stick with what ia in flight don t spaff more on development. I actually think its a brazen lie. The money is to pay themselves. Well just say No.
Of 76 remaining staff, 11 are "open to new work" including the Chief People Officer and also a bunch of case handlers. This is pretty much a double underscore of the Titanic heavily listing and most rafts are now deployed. Even the Violinists have fckd off:-))
Such painful reading. The Devote funding is not a lump sum that gets handed over and its not used for operationally running the business you absolute fool.